跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Abluent - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Abluent
Approved
STANDARD
Abluent
J.M. Tolmann Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3c9c335f32a700c5
Company
J.M. Tolmann Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
3c9c335f32a700c5
Drug Approval Philippines Name
Abluent
Product Name
Abluent
Registration Number
HRP-028
Brand Name
Abluent
Generic Name
Carbocisteine
Dosage Form
Suspension
Dosage Strength
250mg/ 5mL
Manufacturer
J.M. Tolmann Laboratories, Inc.
Issuance Date
29 May 2023
Expiry Date
03 June 2028
Pharmacologic Category
MUCOLYTICS
Classification
Household Remedy (HR)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3c9c335f32a700c5
Type
Standard
Back to Philippines FDA Approvals